Comparative effects of fosinopril and nifedipine on regression of left ventricular hypertrophy in hypertensive patients: A double-blind study
- 1 February 1995
- journal article
- clinical trial
- Published by Springer Nature in Cardiovascular Drugs and Therapy
- Vol. 9 (1) , 141-143
- https://doi.org/10.1007/bf00877754
Abstract
The effects of fosinopril and nifedipine on left ventricular (LV) mass were evaluated in 35 hypertensive patients with LV mass index greater than 110 g/m2 in female and 130 g/m2 in male patients. The goal of therapy was also to obtain a seated diastolic blood pressure (SDBP) of less than 90 mmHg. The patients were studied by echocardiography after 2 weeks of placebo treatment and 4, 12, and 24 weeks of monotherapy with active drugs. Both fosinopril and nifedipine reduced SDBP to a normal level after 6 months of treatment (p<.001). Regression of LV hypertrophy was achieved by either agent (p<.001), with fosinopril being more effective than nifedipine (p<.002). In conclusion, both fosinopril and nifedipine effectively reduce SDBP and achieve important regression of LV hypertrophy.Keywords
This publication has 25 references indexed in Scilit:
- Once-daily fosinopril in the treatment of hypertension.Hypertension, 1991
- Left Ventricular Hypertrophy and Antihypertensive TherapyDrugs, 1988
- Left Ventricular HypertrophyDrugs, 1988
- Captopril and nifedipine in combination for moderate to severe essential hypertension.Hypertension, 1987
- Echocardiographic studies of regression of left ventricular hypertrophy in hypertension.Hypertension, 1987
- Reproducibility of echocardiographic left ventricular measurements.Hypertension, 1987
- Reversal of cardiac hypertrophy in humans.Hypertension, 1984
- Calcium-channel blockade with nifedipine and angiotensin converting-enzyme inhibition with captopril in the therapy of patients with severe primary hypertension.Circulation, 1984
- Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method.Circulation, 1977
- Essential HypertensionCirculation, 1966